Literature DB >> 5284835

Cytosine arabinoside in acute granulocytic leukemia.

B Goodell, B Leventhal, E Henderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5284835     DOI： 10.1002/cpt1971124599

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  4 in total

1.  A general method for purification of deoxycytidine kinase.

Authors:  A Baxter; L M Currie; J P Durham
Journal:  Biochem J       Date:  1978-09-01       Impact factor: 3.857

2.  Prolonged remission maintenance in acute myeloid leukaemia.

Authors:  A S Spiers; J M Goldman; D Catovsky; C Costello; D A Galton; C S Pitcher
Journal:  Br Med J       Date:  1977-08-27

Review 3.  The toxicity of cytarabine.

Authors:  J Stentoft
Journal:  Drug Saf       Date:  1990 Jan-Feb       Impact factor: 5.606

4.  Therapy of refractory/relapsed acute myeloid leukemia and blast crisis of chronic myeloid leukemia with the combination of cytosine arabinoside, tetrahydrouridine, and carboplatin.

Authors:  J H Marsh; W Kreis; B Barile; S Akerman; P Schulman; S L Allen; L C DeMarco; M W Schuster; D R Budman
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.